Phase II study of panitumumab with irinotecan for patients with KRAS wild-type metastatic colorectal cancer (MCRC) refractory to standard chemotherapy: A GERCOR study.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 3573-3573 ◽  
Author(s):  
B. Chibaudel ◽  
C. Tournigand ◽  
M. Mabro ◽  
M. Bennamoun ◽  
P. Artru ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Wild Type ◽  
Standard Chemotherapy

scholarly journals Phase II study of cetuximab rechallenge in patients with ras wild-type metastatic colorectal cancer: E-rechallenge trial

2018 ◽  
Vol 29 ◽  
pp. viii161 ◽  
Author(s):  
H. Osawa ◽  
E. Shinozaki ◽  
M. Nakamura ◽  
Y. Ohhara ◽  
Y. Shindo ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Wild Type
Sign in / Sign up

Export Citation Format

Share Document